Home › BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay To Acclerate Epigenetic Drug Discovery
 

Keywords :   


BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay To Acclerate Epigenetic Drug Discovery

2013-08-15 06:45:51| drugdiscoveryonline News Articles

Methyltransferasesare key players in epigenetic control of gene expression and have become the targets of intensive public and private drug discovery efforts

Tags: generation drug discovery labs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »